Clinical Trial Update: A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2, single-arm multicenter trial evaluating neoadjuvant therapy with Adebrelimab plus Apatinib for resectable non-small cell lung cancer; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: The First Affiliated Hospital of Xiamen University | Conditions: Non-Small Cell Lung Cancer, Adebrelimab | Phase 2 | Status: NOT_YET_RECRUITING